A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD)
Clinical trial NCT03392987 · COMPLETED
Trial details
- NCT number
- NCT03392987
- Sponsor
- Orchard Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-25
- Primary completion
- 2022-04-06
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.